A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
Columbia researchers have developed a method to generate hypothalamic-like neurons from human pluripotent stem cells, which could aid the study of obesity.
Using advanced DNA sequencing methods, researchers have identified a new gene that is associated with sporadic amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease.
Four researchers—two P&S faculty members and two visiting international scientists—have been named Schaefer Research Scholars to pursue research projects in human physiology.
Ross Frommer testifies about the importance of state investments to keep scientists in New York, citing an investment of less than $1 million that resulted in much higher gains.
Using the same technology that made smartphone cameras possible, Columbia scientists are capturing images of molecules at a level of detail never before possible.
Two Columbia University Medical Center faculty members were present today when President Obama provided details of the precision medicine initiative he announced during this year’s State of the Union address.
Researchers worldwide rely on the New York Brain Bank’s extensive collection of dissected and catalogued brain tissue for their work in neurodegenerative diseases.
Biogen Idec and Columbia University Medical Center have formed a $30 million strategic alliance to conduct genetics discovery research on the underlying causes of disease and to identify new treatment approaches.